Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

TANDLÆGESELSKABET COLOSSEUMKLINIKKEN HERLEV ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   4.8% 4.4% 3.3% 3.1% 2.3% 1.1% 6.4% 6.4%   Credit score (0-100)   46 48 54 54 64 83 37 37   Credit rating   BBB BBB BBB BBB BBB A BBB BBB   Credit limit (kDKK)   0.0 -0.0 0.0 0.0 0.1 454.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   10,340 17,787 20,614 26,301 22,840 23,631 0.0 0.0   EBITDA   -597 284 2,483 6,461 5,593 5,506 0.0 0.0   EBIT   -1,734 -1,859 243 3,254 2,874 3,357 0.0 0.0   Pre-tax profit (PTP)   -2,151.5 -2,708.8 -656.7 2,704.0 2,457.8 3,227.4 0.0 0.0   Net earnings   -2,151.5 -2,708.8 -656.7 2,704.0 2,457.8 3,647.3 0.0 0.0   Pre-tax profit without non-rec. items   -2,151 -2,709 -657 2,704 2,458 3,227 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   12,610 12,662 11,392 9,048 7,009 5,415 0.0 0.0   Shareholders equity total   -1,259 -3,968 -4,624 -1,920 537 4,185 3,928 3,928   Interest-bearing liabilities   3,263 7,700 6,925 3,681 0.0 0.0 0.0 0.0   Balance sheet total (assets)   16,796 18,501 17,094 13,699 9,391 10,087 3,928 3,928   Net Debt   2,923 6,402 4,593 2,291 -131 -298 -3,753 -3,753     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   10,340 17,787 20,614 26,301 22,840 23,631 0.0 0.0   Gross profit growth   -1.3% 72.0% 15.9% 27.6% -13.2% 3.5% -100.0% 0.0%   Employees   16 25 28 26 26 23 0 0   Employee growth %   14.3% 56.3% 12.0% -7.1% 0.0% -11.5% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   16,796 18,501 17,094 13,699 9,391 10,087 3,928 3,928   Balance sheet change%   172.9% 10.2% -7.6% -19.9% -31.4% 7.4% -61.1% 0.0%   Added value   -597.2 283.9 2,483.0 6,461.0 6,081.5 5,506.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   10,441 -2,491 -3,957 -5,998 -5,152 -4,215 -5,415 0   Net sales trend   -1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 -4.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -16.8% -10.5% 1.2% 12.4% 12.6% 14.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -13.6% -8.3% 1.2% 17.5% 23.0% 34.8% 0.0% 0.0%   ROI %   -18.2% -11.2% 1.7% 30.0% 59.6% 114.3% 0.0% 0.0%   ROE %   -18.7% -15.3% -3.7% 17.6% 34.5% 154.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -7.0% -17.7% -21.7% -12.6% 5.8% 42.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -489.5% 2,255.3% 185.0% 35.5% -2.3% -5.4% 0.0% 0.0%   Gearing %   -259.2% -194.1% -149.8% -191.7% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   10.2% 18.7% 12.5% 10.5% 22.6% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.4 0.4 0.3 0.3 0.2 0.8 0.0 0.0   Current Ratio   0.4 0.4 0.3 0.3 0.2 0.8 0.0 0.0   Cash and cash equivalent   339.6 1,297.5 2,331.6 1,389.8 131.3 298.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -2,574.0 -5,472.6 -10,559.8 -7,796.6 -5,378.4 -855.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -37 11 89 249 234 239 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -37 11 89 249 215 239 0 0   EBIT / employee   -108 -74 9 125 111 146 0 0   Net earnings / employee   -134 -108 -23 104 95 159 0 0